MANHATTAN BEACH, Calif., Feb. 14, 2011/PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced that Anthony J. Cataldo, President and Chief Executive Officer, and Robert Brooke, a strategic advisor to the Company, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies On-Line Forum on Thursday, February 17, 2011 at 10:30 a.m. Eastern (7:30 a.m. Pacific).
A webcast of the presentation will be accessible online on at the PrecisionIR event site: http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=163285. An archived version will be available for 30 days.
About Genesis Biopharma, Inc.
Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the company, visit www.genesis-biopharma.com.
SOURCE Genesis Biopharma, Inc.
